Skip to content
Home/Companies/Esperion Therapeutics
ET

Esperion Therapeutics

·Active
Entry
–
Hold
–
Status
Active
Est. EV
–

Who owns Esperion Therapeutics?

Esperion Therapeutics is currently owned by ARCHIMED through MED I (2014 vintage).

Hand-verified · updated 2026-05-07

ARCHIMED
Investor
ARCHIMED
MED I · 2014 · Buyout

Key facts

StatusActive

More from MED I

Other portfolio companies in the same fund.

Stago
Active
MedTechFrance· 2026
Fytexia
Exited 2023
HealthTechFrance· 2016
to
Micromed
Exited 2023
MedTechFrance· 2016
to
Natural Origins
Exited 2017
HealthTechFrance· 2016
to
Polyplus
Exited 2023
BiotechFrance· 2016
to
Deallus
Exited 2024
PharmaUK· 2015
to
Data refreshed weekly · Sourced from public filings